Cytoreductive surgery and post-operative heated pleural chemotherapy for the management of pleural surface malignancy

References

• International Pleural Lavage Cytology Collaborators. Impact of positive pleural lavage cytology on survival in patients having lung resection for non-small cell lung cancer: An international individual patient data meta-analysis. J Thorac Cardiovasc Surg 2010;139:1441–6
   Google Scholar
• Kodama K, Doi O, Tatsuta M, Kuriyama K, Tateishi R. Development of postoperative intrathoracic chemo-thermotherapy for lung cancer with objective of improving local cure. Cancer 1989;64:1422–8
   PubMed Web of Science ®Google Scholar
• Fujimoto S, Takahashi M, Mutou T, Kobayashi K, Toyosawa T. Successful intraperitoneal hyperthermic chemoperfusion for the prevention of postoperative peritoneal recurrence in patients with advanced gastric carcinoma. Cancer 1999;85:529–34
   PubMed Web of Science ®Google Scholar
• Urano M, Kuroda M, Nishimura Y. For the clinical application of thermochemotherapy given at mild temperatures. Int J Hyperthermia 1999;15:79–107
   PubMed Web of Science ®Google Scholar
• Mohamed F, Marchettini P, Stuart OA, Urano M, Sugarbaker PH. Thermal enhancement of new chemotherapeutic agents at moderate hyperthermia. Ann Surg Oncol 2003;10:463–8
   PubMed Web of Science ®Google Scholar
• Kodama K, Doi O, Higashiyama M, Yokouchi H, Tatsuta M. Long-term results of postoperative intrathoracic chemo-thermotherapy for lung cancer with pleural dissemination. Cancer 1993;72:426–31
   PubMed Web of Science ®Google Scholar
• International Mesothelioma Interest Group. A proposed new international TNM staging system for malignant pleural mesothelioma. Chest 1995;108:1122–8
   Google Scholar
• Masaoka A, Monden Y, Nakahara K, Tanioka T. Follow-up study of thymomas with special reference to their clinical stages. Cancer 1981;48:2485–92
   PubMed Web of Science ®Google Scholar
• Kato H, Hiraoka M, Nakajima T, Ishida T. Deep-heating characteristics of a RF capacitive heating device. Int J Hyperthermia 1985;1:15–28
   PubMedGoogle Scholar
• Paliwal BR, Gehring MA, Sanders C, Mackie TR, Raffety HM, Song CW. 3D rendering of SAR distributions from Thermotorn RF-8 using a ray casting technique. Int J Hyperthermia 1991;7:567–75
   PubMed Web of Science ®Google Scholar
• Lee CK, Song CW, Rhee JG, Levitt SH. Clinical experience with Thermotron RF-8 capacitive heating for bulky tumors: University of Minnesota experience. Radiol Clin North Am 1989;27:543–8
   PubMed Web of Science ®Google Scholar
• Xia H, Karasawa K, Hanyu N, Chang TC, Okamoto M, Kiguchi Y, et al. Hyperthermia combined with intra-thoracic chemotherapy and radiotherapy for malignant pleural mesothelioma. Int J Hyperthermia 2006;22:613–21
   PubMed Web of Science ®Google Scholar
• Ohguri T, Yahara K, Moon SD, Yamaguchi S, Imada H, Terashima H, Korogi Y. Deep regional hyperthermia for the whole thoracic region using 8 MHz radiofrequency-capacitive heating device: Relationship between the radiofrequency-output power and the intra-oesophageal temperature and predictive factors for a good heating in 59 patients. Int J Hyperthermia 2011;27:20–26
   PubMed Web of Science ®Google Scholar
• Japan Lung Cancer Society. General Rule for Clinical and Pathological Record of Lung Cancer. 6th ed. Tokyo: Kanehara, 2003
   Google Scholar
• Doi O, Kodama K, Tatsuta M, Higashiyama M, Aoki Y, Kuriyama K, et al. Effectiveness of intrathoracic chemothermotherapy for malignant pleurisy due to Ewing’s sarcoma: A case report. Int J Hyperthermia 1990;6:963–9
   PubMed Web of Science ®Google Scholar
• Kodama K, Higashiyama M, Tokunaga T. Postoperative intrathoracic chemo-thermotherapy (PICT) in pleural surface malignancy (in Japanese). Surgery Frontier 2012;19:159–67
   Google Scholar
• Debes A, Rommel F, Breise M, Willers R, Göbel U, Wessalowski R, et al. In vitro test-system for chemo- and thermosensitivity: An analysis of survival fraction and cell-cycle distributions in human Ewing’s sarcomas as a model for tumors in pediatric oncology. Klin Pediatr 2002;214:223–9
   PubMedGoogle Scholar
• Ohguchi Y, Watanabe N, Niitsu Y, Doi O, Kodama K. A simulation model of hyperthermia by RF capacitive heating. IEICE Trans Inf Syst 1992;E75-D:219–26
   Google Scholar
• Wiedemann GJ, d’Oleire F, Knop E, Eleftheriadis S, Bucsky P, Feddersen S, et al. Ifosfamide and carboplatin combined with 41.8 °C whole-body hyperthermia in patients with refractory sarcoma and malignant teratoma. Cancer Res 1994;54:5346–50
   PubMedGoogle Scholar
• Kodama K, Doi O, Kurokawa E, Kawasaki S, Terasawa T. Local chemo-thermotherapy for lung cancer [in Japanese]. Haigan 1987;27:133–40
   Google Scholar
• Refaely Y, Simansky DA, Paley M, Gottfried M, Yellin A. Resection and perfusion thermochemotherapy: A new approach for the treatment of thymic malignancies with pleural spread. Ann Thorac Surg 2001;72:366–70
   Google Scholar
• Kondo K, Monden Y. Therapy for thymic epithelial tumors: A clinical study of 1,320 patients from Japan. Ann Thorac Surg 2003;76:878–85
   PubMed Web of Science ®Google Scholar
• Wright CD. Pleuropneumonectomy for the treatment of Masaoka stage IVA thymoma. Ann Thorac Surg 2006;82:1234–9
   Google Scholar
• Haung J, Rizk NP, Travis WD, Seahan VE, Bains MS, Dycoco J, et al. Feasibility of multimodality therapy including extended resections in stage IVa thymoma. J Thorac Cardiovasc Surg 2007;134:1477–84
   Google Scholar
• Ishikawa Y, Matsuguma H, Nakahara R, Suzuki H, Ui A, Kondo T, et al. Multimodality therapy for patients with invasive thymoma disseminated into the pleural cavity: The potential role of extrapleural pneumonectomy. Ann Thorac Surg 2009;88:952–7
   Google Scholar
• Lucchi M, Davini F, Ricciardi R, Duranti L, Boldrini L, Palmiero G, et al. Management of pleural recurrence after curative resection of thymoma. J Thorac Cardiovasc Surg 2009;137:1185–9
   Google Scholar
• Siesling S, van der Zwan JM, Izarzugaza I, Jaal J, Treasure T, Foschi R, et al. Rare thoracic cancers, including peritoneum mesothelioma. Eur J Cancer 2012;48:949–60
   PubMed Web of Science ®Google Scholar
• Yellin A, Simansky DA, Ben-Avi R, Perelman M, Zeitlin N, Refaely Y, et al. Resection and heated pleural chemoperfusion in patients with thymic epithelial malignant disease and pleural spread: A single-institution experience. J Thorac Cardiovasc Surg 2013;145:83–9
   Google Scholar
• Monneuse O, Beaujard AC, Guibert B, Gilly FN, Mulsant P, Carry PY, et al. Long-term results of intrathoracic chemohyperthermia (ITCH) for the treatment of pleural malignancies. Br J Cancer 2003;88:1839–43
   Google Scholar
• Richards WG, Zellos L, Bueno R, Jaklitsch MT, Jänne PA, Chirieac LR, et al. Phase I to II study of pleurectomy/decortication and intraoperative intracavitary hyperthermic cisplatin lavage for mesothelioma. J Clin Oncol 2006;24:1561–7
   PubMed Web of Science ®Google Scholar
• Rice DC, Stevens CW, Correa AM, Vaporciyan AA, Tsao A, Forster KM, et al. Outcomes after extrapleural pneumonectomy and intensity-modulated radiation therapy for malignant pleural mesothelioma. Ann Thorac Surg 2007;84:1685–93
   PubMed Web of Science ®Google Scholar
• Tilleman TR, Richards WG, Zellos L, Johnson BE, Jaklitsch MT, Mueller J, et al. Extrapleural pneumonectomy followed by intracavitary intraoperative hyperthermic cisplatin with pharmacologic cytoprotection for treatment of malignant pleural mesothelioma: A phase II prospective study. J Thorac Cardiovasc Surg 2009;138:405–11
   PubMed Web of Science ®Google Scholar
• Tokunaga T, Higashiyama M, Okami J, Maeda J, Fujiwara A, Kodama K. Intrathoracic chemo-thermotherapy with radiofrequency waves after extrapleural pneumonectomy for malignant pleural mesothelioma. Interact Cardiovasc Thorac Surg 2011;13:267–70
   Google Scholar
• Sugerbaker DJ, Gill RR, Yeap BY, Wolf AS, DaSilva MC, Baldini EH, et al. Hyperthermic intraoperative pleural cisplatin chemotherapy extends interval to recurrence and survival among low-risk patients with malignant pleural mesothelioma undergoing surgical macroscopic complete resection. J Thorac Cardiovasc Surg 2013;145:955–63
   Google Scholar
• Sawabata N, Matsumura A, Motohiro A, Osaka Y, Gennga K, Fukai S, et al. Malignant minor pleural effusion detected on thoracotomy for patients with non-small cell lung cancer: Is tumor resection beneficial for prognosis? Ann Thorac Surg 2002;73:412–15
   PubMed Web of Science ®Google Scholar
• Muraoka M, Oka T, Akamine S, Tagawa T, Morinaga M, Inoue M, et al. Modified intrapleural cisplatin treatment for lung cancer with positive pleural lavage cytology or malignant effusion. J Surg Oncol 2006;93:323–9
   Google Scholar
• Seto T, Ushijima S, Yamamoto H, Ito K, Araki J, Inoue Y, et al. Intrapleural hypotonic cisplatin treatment for malignant pleural effusion in 80 patients with non-small-cell lung cancer: A multi-institutional phase II trial. Br J Cancer 2006;95:717–21
   PubMed Web of Science ®Google Scholar
• Ueda K, Maeda F, Ito Y. Combined treatment with low dose chemotherapy and regional hyperthermia for progressive urothelial cancer. Thermal Med 2011;27:109–12
   Google Scholar
• Issels RD, Lindner LH, Verweij J, Wust P, Reichardt P, Schem BC, et al. Neo-adjuvant chemotherapy alone or with regional hyperthermia for localized high-risk soft-tissue sarcoma: A randomized phase 3 multicentre study. Lancet Oncol 2010;11:561–70
   PubMed Web of Science ®Google Scholar
• Higashiyama M, Kodama K, Yokouchi H, Takami K, Nakayama T, Horai T. Clinical value of pleural lavage cytological positivity in lung cancer patients without intraoperative malignant pleuritis. Recurrent pattern based on semiquantitative analysis of tumor cells in pleural lavage. Jpn J Thorac Cardiovasc Surg 2000;48:611–17
   Google Scholar
• Kim ES, Lee JJ, He G, Chow CW, Fujimoto J, Kalhor N, et al. Tissue platinum concentration and tumor response in non-small-cell lung cancer. J Clin Oncol 2012;30:3345–52
   PubMed Web of Science ®Google Scholar